Second Sight Medical Products Inc
EYESNASDAQ·US · USD
$29.20
-0.07 (-0.24%)
Prices as of October 2, 2026 · market closedPrice
Key statistics
Valuation
Market cap0.00 USD
Enterprise value-69.36M USD
Trailing P/E33.24
Forward P/E-2.96
PEG ratio0.00
Price / sales0.00
Price / book5.98
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-12.59%
Return on equity-47.01%
Income (TTM)
Revenue0.00 USD
Gross profit130.00K USD
EBITDA0.00 USD
Net income-8.92M USD
Diluted EPS-$0.81
Rev. growth (YoY)0.00%
Balance sheet
Total cash39.00K USD
Total debt151.00K USD
Debt / equity0.01
Current ratio39.52
Book value / share$1.04
Cash flow (TTM)
Operating cash flow-8.13M USD
Levered free cash flow-8.92M USD
Shares & price
Shares outstanding10.94M
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$28.78
200-day MA$37.58
52-week high$1,098.90
52-week low$23.90
Dividends
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-021.211.53+26.45%2026-06-10-0.77-1.36−76.62%2026-05-281.231.28+4.07%2020-11-12—-0.07—2020-08-13-0.41-0.15+63.41%
About Second Sight Medical Products Inc
The fund is an exchange-traded fund ("ETF") that seeks to meet its objective by having Corgi Strategies, LLC (the "adviser") actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the development and deployment of technologies that collect, process, secure, analyze, and operationalize data for monitoring, risk management, security, compliance, and operational visibility across public and private environments. It is non-diversified.
- Headquarters
- United States
- Website
- www.secondsight.com